Cardiac Prosthetic Devices Market Size, Share, Growth, Outlook, and Opportunity Analysis, Forecast 2020 - 2027

                                                                               

     Cardiac Prosthetic Devices Market

Cardiac prosthetic devices are artificial heart tissue repair and replacement devices that are implanted permanently or temporarily. Some of the most often used cardiac prosthetic devices include prosthetic heart valves, ventricular assist devices, pacemakers, and annuloplasty rings. To avoid retrograde blood flow and leakages, heart valves such as mechanical, tissue (stented/stent-less), and transcatheter valves are utilised. Pacemakers, on the other hand, employ electrical impulses to maintain a constant heart beat. These devices are designed to replicate the normal working of cardiovascular organs while also assisting in the prevention of additional heart valve blockages.

The rising prevalence of several cardiovascular indications, such as atrial fibrillation, cardiac valve failure, and stroke, which leads to high mortality rates and stroke among geriatrics, are driving the global Cardiac Prosthetic Devices Market. In 2018, more than 40% of the adult population in the United States was diagnosed with a cardiovascular disease, according to the Global Health and Wellness Report - 2018.Furthermore, increased demand for minimally invasive procedures, new technology breakthroughs, high device adaptation rates, and steady growth in the geriatric population are all expected to boost the market's growth. However, the strict licencing procedure for these devices, as well as some provisions of the Affordable Healthcare Act, are constraining industry expansion.


Market Segmentation:

by Product Type:

• Valves

• Pacemakers

• Implantable Pacemakers

• External Pacemakers

• Others

by End-User:

• Hospitals, Clinics and Cardiac Centers

• Ambulatory Surgical Centers

• Others

In 2015, mechanical valves were one of the most profitable subsegments. The robust raw materials utilised in production contribute to their growth by providing patients with a long-term solution. Furthermore, polymeric materials are commonly used as raw materials, reducing the clinical issues that mechanical valves might cause. With this type of valve, there is less of a need for repetitive procedures, which is predicted to be another element in boosting the target market.

The major players operating in the global cardiac prosthetic devices market include, Abbott Laboratories,Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation, BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios, Lepu Medical, Lifetech Scientific, LivaNova, Medtronic plc, Meril Life Sciences, MicroPort Scientific, Shree Pacetronix, TTK Healthcare, Venus Medtech, and Vitatron.